pentobarbital will lower the extent or influence of linagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. Use of other solutions is strongly advisable when linagliptin is to be administered with a CYP3A4 inducer

The usage of barbiturates as sedatives from the postoperative surgical time period and as adjuncts to most cancers chemotherapy is nicely recognized

pentobarbital will minimize the level or effect of clarithromycin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Mysterious.

pentobarbital will decrease the extent or result of finasteride by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Unidentified.

benzhydrocodone/acetaminophen and pentobarbital equally improve sedation. Steer clear of or Use Alternate Drug. Limit use to sufferers for whom alternate remedy choices are insufficient

Monitor Closely (1)pentobarbital will reduce the extent or outcome of exemestane by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. For patients obtaining exemestane with a potent CYP3A4 inducer the proposed dose of exemestane is fifty mg every day after a food.

Contraindicated (one)pentobarbital will lower the extent or influence of lumefantrine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with robust CYP3A4 inducers can result in lowered serum concentrations and loss of antimalarial efficacy

pentobarbital will minimize the extent or impact of methadone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.

pentobarbital will lower the extent or effect of colchicine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.

pentobarbital will minimize the level or result of cevimeline by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Unfamiliar.

pentobarbital will minimize the extent or outcome of alfentanil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unknown.

pentobarbital will reduce the level or effect of ambrisentan by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Mysterious.

pentobarbital will lower the level or outcome of nimodipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unfamiliar.

pentobarbital will minimize the extent or outcome of eltrombopag by impacting hepatic enzyme more info CYP2C9/10 metabolism. Use Warning/Keep track of.